BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Cloud DX Announces Commencement of Trading on the Toronto Venture Exchange

  Cloud DX Inc. is pleased to announce the commencement of trading on Thursday April 15th, 2021, on TSX Venture Exchange under the ticker symbol CDX.

  April 14, 2021

   · 

  3 min read
• Cell Separation Market | Expansive Coverage on the Latest Trends and Developments in the Market

  The growth of the global cell separation market is estimated to be driven by the growing interest of scientists and biotechnology companies in stem cell research.

  April 14, 2021

   · 

  3 min read
• Pharm Country

  New York Academy of Sciences opens nominations for 2022 Innovators in Science Award in Gastroenterology

  Early-career scientist, outstanding senior scientist each to receive US$200,000 in program sponsored by Takeda Pharmaceuticals

  April 14, 2021

   · 

  3 min read
• BioForest

  Magnolia Medical Launches New “Diverted” Multi-Media Advertising Campaign to Educate Healthcare Providers on Benefits of Steripath®

  Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial Specimen Diversion Device® platform.

  April 14, 2021

   · 

  4 min read
• Biotech Beach

  Biogennix Launches Agilon Strip Advanced Bone Grafting Solution

  Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, today announced the launch of its new Agilon® Strip bone grafting product.

  April 14, 2021

   · 

  3 min read
• Deals

  CytomX Therapeutics Announces New Employment Inducement Grants - Apr 14, 2021

  CytomX Therapeutics, Inc. announced that on April 1, 2021, the Company granted a new employee an option to purchase a total of 120,000 shares of the Company’s common stock at an exercise price per share equal to $7.87, which was the closing trading price on April 1, 2021, the date of the grant.

  April 14, 2021

   · 

  3 min read
• Business

  Harrow Health Announces Preliminary First Quarter 2021 Financial Results

  Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for the first quarter ended March 31, 2021.

  April 14, 2021

   · 

  6 min read
• StemSynergy Therapeutics’ Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells

  A major scientific breakthrough in the development of novel cancer therapeutics targeting the Notch pathway has been published online ahead of print in the journal Cancer Research.

  April 14, 2021

   · 

  3 min read
• Business

  Universal Health Services, Inc. Announces Date for First Quarter 2021 Earnings Release and Conference Call

  Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2021 after the market closes on Monday, April 26, 2021.

  April 14, 2021

   · 

  1 min read